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ABSTRACT
KEGG (http://www.kegg.jp/ or http://www.genome.jp/
kegg/) is an encyclopedia of genes and genomes. As-
signing functional meanings to genes and genomes
both at the molecular and higher levels is the primary
objective of the KEGG database project. Molecular-
level functions are stored in the KO (KEGG Orthol-
ogy) database, where each KO is defined as a func-
tional ortholog of genes and proteins. Higher-level
functions are represented by networks of molecular
interactions, reactions and relations in the forms of
KEGG pathway maps, BRITE hierarchies and KEGG
modules. In the past the KO database was devel-
oped for the purpose of defining nodes of molecular
networks, but now the content has been expanded
and the quality improved irrespective of whether or
not the KOs appear in the three molecular network
databases. The newly introduced addendum cate-
gory of the GENES database is a collection of indi-
vidual proteins whose functions are experimentally
characterized and from which an increasing number
of KOs are defined. Furthermore, the DISEASE and
DRUG databases have been improved by systematic
analysis of drug labels for better integration of dis-
eases and drugs with the KEGG molecular networks.
KEGG is moving towards becoming a comprehen-
sive knowledge base for both functional interpreta-
tion and practical application of genomic informa-
tion.
INTRODUCTION
In 1995, KEGG (Kyoto Encyclopedia of Genes and
Genomes) was originally developed as an integrated
database resource for biological interpretation of com-
pletely sequenced genomes by KEGG pathway mapping,
the procedure to map genes in the genome to manually cre-
ated pathway maps. At that time, KEGG consisted of only
four databases, PATHWAY, GENES, COMPOUND and
ENZYME and KEGG pathway mapping was performed
through ENZYME because the database contained only
metabolic pathway maps. KEGG was later significantly ex-
panded, PATHWAY supplemented by BRITE and MOD-
ULE, GENES expanded with GENOME, COMPOUND
supplemented by GLYCAN and REACTION, and EN-
ZYME replaced by KO for the role of KEGG pathway
mapping. KEGG also became more widely used for ana-
lyzing not only genomics data but also transcriptomics, pro-
teomics, glycomics, metabolomics, metagenomics and other
high-throughput data.
After more than 20 years, we wish to make KEGG a
more comprehensive knowledge base for assisting biolog-
ical interpretations of large-scale molecular datasets. In the
past, our efforts focused on developing the databases for
higher-level functions, the PATHWAY, BRITE and MOD-
ULE databases, and KOs were defined as network nodes
of these databases. Consequently, the content of molecular-
level functions in the KO database was incomplete. This is
no longer the case. We have started expending major efforts
to improve and expand theKOdatabase. First, existingKOs
are linked to experimentally characterized protein sequence
data with proper reference information. Second, published
reports on characterizing protein functions are identified,
sequence data are registered in the addendum category of
the KEGGGENES database (1), and new KOs are defined
accordingly.
The KEGG DRUG and DISEASE databases were re-
leased in 2005 and 2008, respectively, and the KEGG
MEDICUS resource (2) integrating these databases with
drug labels (package inserts) was initiated in 2009. While
the content of KEGG is derived mostly from published
research articles, drug labels and other regulatory docu-
ments used in society are now also examined. For drug la-
bels, the entire content is systematically analyzed, for exam-
ple, to characterize drug–drug interactions associated with
contraindications and to define drug-disease links that are
meaningful in practice. The analysis results are used in the
development of DISEASE, DRUG, PATHWAY and other
databases. This paper describes these new developments of
the KEGG database resource.
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OVERVIEW AND NEW FEATURES
KEGG databases
KEGG is an integrated database resource consisting of fif-
teen manually curated databases and a computationally
generated database in four categories as shown in Table
1. The databases in the systems information category are
PATHWAY, BRITE and MODULE, which constitute the
reference knowledge base for understanding higher-level
systemic functions of the cell and the organism, including
metabolism, other cellular processes, organismal functions
and human diseases. The KO database in the genomic in-
formation category is another unique database, in which
knowledge of molecular-level functions is organized with
the concept of functional orthologs. This category also con-
tains GENOME and GENES, which are derived from Ref-
Seq (3), Genbank (4) and NCBI Taxonomy (5) databases
and given KEGG original annotations. SSDB is an aux-
iliary, computationally generated database used for KO-
based annotation of the GENES database.
The databases in the chemical information category
are COMPOUND, GLYCAN, REACTION, RCLASS and
ENZYME, which are collectively called KEGG LIG-
AND. ENZYME is taken from the enzyme nomenclature
database ExplorEnz (6) and given additional annotation of
sequence data links (1). The health information category
consists of DISEASE, DRUG, DGROUP and ENVIRON
shown in Table 1 and two outside databases for drug labels:
Japanese drug labels obtained from the JAPIC database and
FDA drug labels obtained from the DailyMed database.
KEGGMEDICUS represents the health information cate-
gory integrated with these drug labels.
As of 1 October 2016 the following changes were made to
KEGG in order to simplify its overall architecture without
the loss of content. First, the RPAIR database for reactant
pairs (7) was discontinued, but its main content for defin-
ing reaction classes (8) remains to be available as pairs of
COMPOUND entries. Second, the DGENES database (7)
for eukaryotic draft genomes was merged into the GENES
database. Third, the plasmids category (1) of the GENES
database was discontinued because plasmid genes could be,
whenever necessary, incorporated in the addendum cate-
gory.
KEGG identifiers and WebLinks
KEGG objects are biological entities from molecular to
higher levels that are represented as database entries in
KEGG. They include concrete objects of genes and pro-
tein, small molecules, reactions, pathways, diseases and
drugs, organisms and viruses, as well as the more concep-
tual objects: KOs, modules and BRITE hierarchies. The
KEGG object identifier or simply the KEGG identifier is
the unique identifier for each KEGG object, which is also
the database entry identifier in KEGG (Table 1). In most
KEGG databases, the identifier takes the form of a pre-
fix and a five-digit number and is called, for example, map
number, K number, C number and D number for PATH-
WAY, KO, COMPOUND and DRUG, respectively. Excep-
tions are GENES identifiers and the EC number for EN-
ZYME. Table 2 shows KEGGWebLinks, a convenient way
to retrieve from or link to the KEGG website using KEGG
identifiers.
Sequence data in KEGG
The GENES database now consists of three categories,
KEGG organisms, viruses and addendum, as shown in
Table 3. The KEGG organisms category is the main
part of GENES consisting of completely or almost com-
pletely sequenced genomes taken from RefSeq and Gen-
Bank databases. Each organism is identified by the three-
or four-letter organism code, such as ‘hsa’ for Homo sapi-
ens. The viruses category is generated from the bi-monthly
release of RefSeq, where individual viral genomes are not
distinguished and the category is identified by the two-
letter code ‘vg’. Viruses are distinguished, when neces-
sary, by the NCBI taxonomy identifier, which often corre-
sponds to multiple sequenced genomes. The addendum cat-
egory is a manually created sequence dataset for function-
ally characterized proteins. It is a publication-based collec-
tion of sequences, mostly author submitted sequences with
GenBank/ENA/DDBJ protein accession numbers (Pro-
teinIDs). This category is identified by the two-letter code
‘ag’. Using these conventions each GENES entry is iden-
tified by the form of ‘org:gene’ (Table 1) where ‘org’ is the
organism code (or the category code) and ‘gene’ is GeneID,
Locus tag or ProteinID depending on the data source.
Architecture of KEGG website
The architecture of KEGG website, both at the KEGG
main site and the GenomeNet mirror site, was updated
on 1 October 2016 and is shown in Table 4. The basic
architecture is unchanged. The KEGG home page is di-
rectly linked to main databases and software tools and
the other top layer pages contain description of and guid-
ance to KEGG. The KEGG2 page in the second layer
is the table of contents listing all KEGG databases and
software tools including those available as GenomeNet
extension databases (MGENOME, MGENES, EXPRES-
SION and OC) and GenomeNet bioinformatics tools
(BLAST/FASTA, KAAS, SIMPCOMP, etc.). The sec-
ond layer is a collection of entry points to KEGG: data-
oriented entry points that correspond to Table 1, newly in-
troduced subject-oriented entry points shown in Table 5,
and organism-specific entry points. Since KEGG is a gen-
eral purpose database coveringmany different types of data,
it is expected that subject-oriented entry points, of which we
may add more, will help the users in specific research areas
to better understand and utilize KEGG.
MOLECULAR-LEVEL FUNCTIONS
Improvement of GENES and KO databases
In protein sequence databases, such as UniProt (9), func-
tional annotation is included in individual sequence en-
tries. In contrast, theKEGGGENES database is annotated
by simply assigning KO identifiers (K numbers) and mak-
ing links to the KO database. The definition field of each
GENES entry contains the data source name in parenthe-
ses, such as (RefSeq) and (GenBank), indicating that the
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Table 1. The KEGG databases
Category Database name Content KEGG identifier
Systems Information KEGG PATHWAY KEGG pathway maps Map number
KEGG BRITE BRITE hierarchies and tables br/ko number
KEGGMODULE KEGG modules M number
Genomic Information KEGG ORTHOLOGY (KO) KO groups for functional orthologs K number
KEGG GENOME KEGG organisms (complete genomes) and selected viruses org code / T number
KEGG GENES Gene catalogs of KEGG organisms, viruses, and addendum category org:gene
KEGG SSDB Sequence similarity among GENES entries (computationally generated)
Chemical Information KEGG COMPOUND Metabolites and other small molecules C number
(KEGG LIGAND) KEGG GLYCAN Glycans G number
KEGG REACTION Biochemical reactions R number
KEGG RCLASS Reaction class RC number
KEGG ENZYME Enzyme nomenclature EC number
Health Information KEGG DISEASE Human diseases H number
(KEGGMEDICUSa) KEGG DRUG Drugs D number
KEGG DGROUP Drug groups DG number
KEGG ENVIRON Crude drugs and health-related substances E number
aKEGGMEDICUS also includes Japanese drug labels obtained from the JAPIC database (http://www.japic.or.jp) and FDA drug labels obtained from the DailyMed database
(http://dailymed.nlm.nih.gov).
Table 2. KEGGWebLinks
Database URL form Example
PATHWAY www.kegg.jp/pathway/<map number> www.kegg.jp/pathway/hsa01521
BRITE (hierachies only) www.kegg.jp/brite/<br/ko number> www.kegg.jp/brite/ko01504
www.kegg.jp/brite/br08303 ndc
MODULE www.kegg.jp/module/<M number> www.kegg.jp/module/M00810
All databases except BRITE www.kegg.jp/entry/<KEGG identifer> www.kegg.jp/entry/K19188
www.kegg.jp/entry/ag:CAD47941
www.kegg.jp/entry/3.7.1.19
Table 3. Seqeunce data collection in KEGG GENES
Category Sequence data Primary data source Gene identifiera
KEGG organisms Genes in complete eukaryotic genomes RefSeq org:geneid
Genes in complete prokaryotic genomes RefSeq (reference genomes), GenBank (other genomes) org:locus tag
Viruses Genes in RefSeq Virus collection RefSeq vg:geneid
Addendum Functionally characterized proteins PubMed ag:proteinid
aorg, three- or four-letter KEGG organism code; vg, Viruses category code; ag, Addendum category code
Table 4. Architecture of KEGG website
Layer Content
Top pages KEGG home (www.kegg.jp)
Release notes, statistics, database/software documents, KEGG API, KGML
DB entry points KEGG2 page for table of contents (www.kegg.jp/kegg/kegg2.html)
Data-oriented entry points (corresponding to Table 1)
Subject-oriented entry points (shown in Table 5)
Organism-specific entry points (for individual genome, multiple genomes, pangenome, organism group)
DB contents Database entries (as those shown in Table 2)
Software toolsa KEGGMapper tools (www.kegg.jp/kegg/mapper.html)
BlastKOALA automatic annotation server (www.kegg.jp/blastkoala/)
GhostKOALA automatic annotation server (www.kegg.jp/ghostkoala/)
aSoftware tools in the KEGG main site excluding those at the GenomeNet mirror site.
Table 5. Subject-oriented entry points to KEGG
Database name Subject
KEGG Cancer Cancer research
KEGG Pathogen Infectious diseases, pathogens and antimicrobial resistance
KEGG Virus Virus research
KEGG Plant Plant research
KEGG Glycan Glycobiology research
KEGG Annotation KO annotation of genes and proteins
KEGG RModule Architecture of metabolic network
definition was given by the original database as shown in
Figure 1A. KEGG original annotation is given in the fol-
lowing KO subfield, K19188 in this case. As shown in Fig-
ure 2, the KO entry K19188 is based on the experimentally
characterized protein sequence CAD47941, which is stored
in the addendum category of the GENES database (Fig-
ure 1B). Among over 20 000 KO entries, about 80% contain
references (PubMed links) and about 60% contain sequence
data links (in October 2016). Sequence data links are given
to the references when sequences submitted by the authors
to GenBank/ENA/DDBJ are identified or when sequences
used in the experiments can be retrieved by cited references
or sequence accessions.
The addendum category has made it possible to de-
fine KOs independently from KEGG organisms (complete
genomes) and has filled the gaps of missing sequence links
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Figure 1. Definition and KO fields of GENES entries. (A) GenBank derived entry nca:Noca 0613 and (B) manually created entry ag:CAD47941 in the
addendum category.
Figure 2. KO entry K19188 defined from an experimentally characterized protein sequence, ag:CAD47941 for EC:3.7.1.19.
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in the KEGG pathway maps. It is now used to associate
sequence data to Enzyme Nomenclature and to create vari-
ous sequence data collections, including antimicrobial resis-
tance genes (1) and cytochrome P450s. The EC number list
of Enzyme Nomenclature contains references reporting ex-
perimental characterization of enzymatic reactions. Unfor-
tunately, however, it does not contain any enzyme sequence
information, and links between sequences and EC numbers
are left to interpretation of individual users and database
developers. The KEGG ENZYME database is now anno-
tated, whenever possible, with sequence data links given by
the same criteria mentioned above.
KO analysis tools
KOs are defined as sequence similarity groups as well as
functional orthologs, so that they can be used for sequence
similarity based KO assignment. There is no pre-defined
threshold of similarity scores, and although the term or-
tholog is used aKOmay consist of a single gene ormay con-
tain only genes from closely related species. When defining
KOs three factors are considered whenever available, path-
ways, gene clusters and phylogeny, as illustrated in Figure 3
for K19188.
Figure 3A shows a part of the nicotinate and nicoti-
namide metabolism pathway (map00760) that corresponds
to the nicotine degradation pyridine pathway module
(M00810) for Nocardioides sp. JS614 (nca), where the gene
Noca 0613 (Figure 1A) for K19188 with EC:3.7.1.19 is
marked red. Figure 3B is the ortholog table for M00810,
which indicates by coloring that this gene is adjacent on
the chromosome to the gene for K19187 for a subunit
of EC:1.5.99.14. The fact that the entire set of genes for
M00810 is present in the Nocardioides genome and that
the genes that are located next to each other on the chro-
mosome are mapped to two consecutive reaction steps on
the pathway confirms correctness of assigning K19188 to
nca:Noca 0613. The pathway and/or gene cluster informa-
tion is not always available, but the phylogenetic informa-
tion can always be considered because theGENES database
is organized according to the NCBI taxonomy and similar-
ity scores of all gene pairs are stored in the SSDB database.
Figure 3C shows a dendrogram, which was obtained by hi-
erarchical clustering of ag:CAD47941 (Figure 1B), the core
sequence of defining K19188, and its neighbors in SSDB,
and by coloring of branches according to the assigned K
number. The dendrogram tool now linked from the SSDB
search result page allows coloring of branches for distin-
guishing multiple K numbers assigned. It is also used, for
example, for viewing phylogenetic relationships andKnum-
ber assignments of antimicrobial resistance genes in KEGG
Pathogen (Table 5).
BlastKOALA tools
BlastKOALA (10) is the web server for automatic anno-
tation (KO assignment) of query amino acid sequences
followed by KEGG Mapper analysis for inferring higher-
level functions. The server makes full use of the improve-
ments made for the GENES and KO databases, includ-
ing the addition of the GENES addendum category, the
precise taxonomic classification of GENES data and the
improvement of KO to sequence links. The taxonomic
classification was used to define ‘non-redundant’ GENES
datasets for BlastKOALA. A non-redundant dataset is a
collection of pangenomes created at the species or genus
level for prokaryotes and at the genus or family level
for eukaryotes by removing redundant sequences but re-
taining functional contents (KO contents) within each
pangenome (1,10). The user may select a combination of
non-redundant pangenome collections considering the exe-
cution time (faster for higher taxonomic ranks) and the an-
notation quality (better for lower taxonomic ranks).
There are three variants of BlastKOALA. The Anno-
tate Sequence tool in KEGG Mapper is an interactive ver-
sion of BlastKOALA, which is suitable when closely re-
lated genomes are already present in KEGG because the
database to be searched is limited to a single pangenome.
The Pathogen Checker tool in KEGG Pathogen allows
search against the dataset of antimicrobial resistance genes
in KEGG and interpretation of drugs or drug groups to
be affected. The third one is the GhostKOALA server us-
ing more rapid GHOSTX (11) rather than BLAST and
is suitable for analysis of large-scale datasets such as
metagenomes (10).
HIGHER-LEVEL FUNCTIONS
Improvement of PATHWAY database
The KEGG PATHWAY database has been and will con-
tinue to be themain database inKEGG. It consists ofmanu-
ally drawn reference pathwaymaps together with organism-
specific pathway maps that are computationally generated
by matching KO assignments in the genome with reference
pathwaymaps. In regularmaps rectangular nodes are linked
to KOs and the matching is shown by coloring. For ex-
ample, the organism-specific glycolysis pathway hsa00010
with green coloring is generated from the hsa (Homo sapi-
ens) genome and the reference pathway map00010. Table 6
shows the list ofmanually drawn pathwaymaps by category.
Chemical structure transformation maps and drug struc-
ture maps are special maps showing relationships between
chemical/drug structures and are not subject to genome-
based expansion. Global maps (map numbers 01100s) and
overview maps (map numbers 01200s) are intended to show
global and overall features ofmetabolism.No rectangles are
used and lines connecting circles (chemical compounds) are
linked to KOs in the reference pathway maps and colored in
the organism-specific pathway maps. An additional feature
of these maps is that KEGGmodules and reaction modules
(12) are embedded in the pathway diagrams.
On average one or two new maps are released every
month, and existing maps are constantly updated. As in-
dicated in Table 6 human diseases have become one of the
major categories of the KEGG PATHWAY database. Re-
cent additions include the subcategories of drug resistance
for both antimicrobial and antineoplastic agents. For exam-
ple, Figure 4A is a disease pathway map for non-small cell
lung cancer (hsa05223), where known genetic alterations
are marked in red. Targeted drug names are given on this
map: Gefitinib (D01977) and Erlotinib (D04023) for EGFR
mutation and Crizotinib (D09731) for ALK fusion gene.
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Figure 3. (A) A portion of the KEGG pathway map of nicotinate and nicotinamide metabolism (map00760) for Nocardioides sp. JS614 (nca), where
Noca 0613 for EC:3.7.1.19 is marked red. (B) Ortholog table for the KEGG module of nicotine degradation pyridine pathway (M00810), where coloring
of positional correlation indicates that Noca 0613 for EC:3.7.1.19 is adjacent to Noca 0612 for EC:1.5.99.14. (C) Dendrogram obtained by hierarchical
clustering of ag:CAD47941 and its neighbors in SSDB, where genes annotated with K19188 are distinguished by coloring.
Table 6. Manually drawn KEGG reference pathway maps
Category Type Number of mapsa
Metabolism Global map 4
Overview map 5
Regular map 160
Chemical structure transformation map 9
Genetic information processing Regular map 22
Environmental information processing Regular map 38
Cellular processes Regular map 24
Organismal systems Regular map 78
Human diseases Regular map 81
Drug development Drug structure map 75
aAs of 1 October 2016.
Figure 4B is a drug resistance map for EGFR tyrosine ki-
nase inhibitor resistance (hsa01521) caused by a secondary
mutation in EGFR or activation of alternative pathways
such as involving MET. A newer generation of EGFR in-
hibitor, Osimertinib (D10766), is for the former type of re-
sistance.
KEGG mapper tools
KEGGMapper is a collection of KEGGmapping tools for
linking molecular objects (genes, proteins, metabolites and
glycans) to higher-level objects (pathways, modules, hierar-
chies, taxonomy and diseases). Table 7 shows the current
list of KEGGmapping tools including the new Search Dis-
ease tool. Two pathwaymapping tools, Search Pathway and
Search&Color Pathway, were made available from the be-
ginning of the KEGG project, and they are still the most
widely used. The mapping of genes and proteins can be
made either in reference mode using KOs or in organism-
specific mode using gene identifiers, such as human gene
identifiers used to search against human pathwaymaps. The
three tools, Reconstruct Pathway, Reconstruct Brite and
ReconstructModule, acceptKOs only. They are linked from
the BlastKOALA andGhostKOALA servers for interpreta-
tion of the KO assignment results.
The tools for characterizing molecular-level functions
(BlastKOALA and GhostKOALA) and higher-level func-
tions (KEGG Mapper tools) have been developed sepa-
rately as general-purpose tools. In contrast the Pathogen
Checker tool, a BlastKOALA variant, contains a focused
KEGG mapping feature against a specific BRITE table file
(br08451) for interpretation of antimicrobial resistance. We
plan to make it easier to select and integrate appropriate
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Figure 4. KEGG pathway maps for (A) non-small cell lung cancer (hsa05223) and (B) EGFR tyrosine kinase inhibitor resistance (hsa01521). Some of the
well-known molecular target drugs are included in these maps.
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Table 7. KEGGMapper tools
Tool Query dataset Database
Search Pathway KOs, gene identifiers, C numbers, etc. PATHWAY
Search&Color Pathway KOs, gene identifiers, C numbers, etc. PATHWAY
Color Pathway KOs, gene identifiers single KEGG pathway map
Color Pathway WebGL KOs, gene identifiers single KEGG pathway map
Search Brite KOs, gene identifiers, C numbers, etc. BRITE
Search&Color Brite KOs, gene identifiers, C numbers, etc. BRITE
Join Brite KOs, D numbers, etc. single BRITE hierarchy
Join Brite Table KOs, D numbers, etc. single BRITE table
Search Module KOs, gene identifiers, C numbers, etc. MODULE
Search&Color Module KOs, gene identifiers, C numbers, etc. MODULE
Search Disease KOs, human gene identifiers DISEASE
Reconstruct Pathway KOs PATHWAY
Reconstruct Brite KOs BRITE
Reconstruct Module KOs MODULE
Map Taxonomy Organism codes, NCBI taxonomy IDs Taxonomy file
tools and datasets for such focused mapping and functional
characterization.
DISEASE AND DRUG INFORMATION
Perturbed KEGG molecular networks
The KEGG pathway maps describe, for example, how
beta-lactam antibiotics are synthesized as natural products
(map00311 for penicillin and cephalosporin, map00332 for
carbapenem and map00261 for monobactam). However,
the pathwaymap of peptidoglycan biosynthesis (map00550)
does not describe how beta-lactams interact with penicillin
binding proteins and affect bacterial cell wall biosynthesis,
because this type of interaction is considered as perturba-
tion to the normal pathway. Similarly, drugs as well as ge-
netic and environmental factors of diseases are considered
as perturbants to the KEGGmolecular networks, and they
are not explicitly shown in the KEGG pathway maps ex-
cept for a small number of disease associated genes marked
in red (Figure 4). Instead, perturbations are described in the
DISEASE and DRUG databases.
The DISEASE database is a collection of disease entries,
each consisting of a list of disease genes, carcinogens (for
cancers), pathogens (for infectious diseases) and other envi-
ronmental factors. TheDRUGdatabase, which is a compre-
hensive collection of approved drugs, contains drug target
information and drug metabolism information, the latter
further divided by metabolizing enzymes and transporters,
as well as by substrates, inhibitors and inducers. Thus, the
DISEASE and DRUG databases may be integrated with
PATHWAY and other molecular network databases to un-
derstand perturbed molecular networks. Computationally
generated pathway maps are available with the special five-
letter organism code ‘hsadd’ for disease genes and drug tar-
gets shown on human pathway maps with coloring of pink
and light blue, respectively.
Systematic analysis of drug labels
One problem of developing the DISEASE database was
how to define a disease entry because, for example, a broad
disease name may represent multiple specific diseases or a
disease may consist of multiple types corresponding to dif-
ferent gene mutations. KEGG DISEASE entries contain
this inherent hierarchy, usually multiple entries created for a
broad name and a specific name, but a single entry covering
multiple types of minor variations. We have recently started
using all Japanese drug labels and selected FDA drug labels
to improve the quality of the DISEASE database. Indica-
tions described in drug labels are used to add or modify dis-
ease entries. Many drugs, especially antineoplastic agents,
are often indicated for narrowly defined diseases with ge-
nomic features, such as ALK-positive non-small cell lung
cancer (Figure 4). Such features are usually treated as differ-
ent types of a single disease and the information about phar-
macogenomic biomarkers is stored in the DRUG database.
As part of the KEGG MEDICUS resource, drug-drug
interactions designated as contraindications or precautions
are extracted from all the Japanese drug labels and stan-
dardized with KEGG identifiers to maintain the drug-drug
interaction database. In drug labels interactions are de-
scribed not only by individual drug names but also by
drug group or drug class names, such as nonsteroidal anti-
inflammatory drug (NSAID). In a similar way as KOs are
defined as network nodes, appropriate grouping is neces-
sary for incorporating drugs into the KEGGmolecular net-
works (1). Drug groups in the KEGG DGROUP database
have been developed for this purpose, such as DG01504 for
NSAID, and they have been systematically compared with
all the Japanese drug labels to improve the content.
Drug labels and other documents regulated by govern-
ment agencies contain rich information with practical rele-
vance that may not be available in research articles. KEGG
is now expanding to incorporate such regulatory informa-
tion in order to make better links between research findings
and practical values.
Accessing KEGG
KEGG is made available at both the KEGG main site
(http://www.kegg.jp/) and theGenomeNet mirror site (http:
//www.genome.jp/kegg/). DBGET queries are available at
both sites, but direct queries against the KEGG relational
databases, as well as some tools, are available only at the
main site. The difference may not be noticeable by the users
because mutual links are made as if they belong to a single
site.
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